<DOC>
	<DOCNO>NCT01139931</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study study biomarker change sample young patient acute myeloid leukemia .</brief_summary>
	<brief_title>Biomarker Changes Samples From Young Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Map key histone modification cytosine methylation leukemia cell line define oncogenic mutation . - Acquire genome-wide map key histone modification cytosine methylation primary leukemia sample patient acute myeloid leukemia ( AML ) . - Investigate functional relationship genetic epigenetic landscape AML . OUTLINE : Archived sample analyze vivo vitro ( cell line ) histone modification cytosine methylation . Genome-wide location 5 histone modification analyze use chip-Seq , well DNA methylation analysis nucleotide-resolution high-throughput bisulfite sequencing . These epigenetic data correlate genomic data ( sequence analysis , expression array , SNP array ) .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia Primary leukemia sample Children Oncology Group ( COG ) bank sufficient number cell ( 500,0001 million cell ) &gt; 80 % leukemia blast PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
</DOC>